Correlation Between Berkshire Hathaway and Nexien Biopharma
Can any of the company-specific risk be diversified away by investing in both Berkshire Hathaway and Nexien Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Berkshire Hathaway and Nexien Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Berkshire Hathaway and Nexien Biopharma, you can compare the effects of market volatilities on Berkshire Hathaway and Nexien Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Berkshire Hathaway with a short position of Nexien Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Berkshire Hathaway and Nexien Biopharma.
Diversification Opportunities for Berkshire Hathaway and Nexien Biopharma
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Berkshire and Nexien is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Berkshire Hathaway and Nexien Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nexien Biopharma and Berkshire Hathaway is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Berkshire Hathaway are associated (or correlated) with Nexien Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nexien Biopharma has no effect on the direction of Berkshire Hathaway i.e., Berkshire Hathaway and Nexien Biopharma go up and down completely randomly.
Pair Corralation between Berkshire Hathaway and Nexien Biopharma
Assuming the 90 days horizon Berkshire Hathaway is expected to generate 269.01 times less return on investment than Nexien Biopharma. But when comparing it to its historical volatility, Berkshire Hathaway is 32.47 times less risky than Nexien Biopharma. It trades about 0.02 of its potential returns per unit of risk. Nexien Biopharma is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 1.70 in Nexien Biopharma on September 5, 2024 and sell it today you would lose (0.30) from holding Nexien Biopharma or give up 17.65% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 98.44% |
Values | Daily Returns |
Berkshire Hathaway vs. Nexien Biopharma
Performance |
Timeline |
Berkshire Hathaway |
Nexien Biopharma |
Berkshire Hathaway and Nexien Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Berkshire Hathaway and Nexien Biopharma
The main advantage of trading using opposite Berkshire Hathaway and Nexien Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Berkshire Hathaway position performs unexpectedly, Nexien Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexien Biopharma will offset losses from the drop in Nexien Biopharma's long position.Berkshire Hathaway vs. American International Group | Berkshire Hathaway vs. Arch Capital Group | Berkshire Hathaway vs. Sun Life Financial | Berkshire Hathaway vs. Hartford Financial Services |
Nexien Biopharma vs. Cann American Corp | Nexien Biopharma vs. Speakeasy Cannabis Club | Nexien Biopharma vs. Benchmark Botanics | Nexien Biopharma vs. Link Reservations |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |